FEMI: Next-Generation AI Platform for Comprehensive IVF Embryo Analysis and Selection

Principal Investigator: 

Iman Hajirasouliha, Associate Professor of Systems and Computational Biomedicine

Background & Unmet Need

  • Current IVF success heavily depends on accurate embryo assessment, requiring multiple complex tasks including ploidy prediction, quality scoring, and developmental monitoring
  • Traditional diagnostic tools are costly, lack standardization, and often rely on invasive procedures like PGT-A testing
  • Current AI models are constrained by insufficient training data diversity, reliance on manual input, and limited accessibility for clinical adoption
  • Available AI platforms show reduced accuracy when analyzing specific developmental stages and lack standardization across different clinical settings
  • High costs and varying regulations around genetic testing create barriers to access for many patients
  • Unmet Need: Efficient non-invasive, and standardized approach for comprehensive embryo assessment

Technology Overview

  • The Technology: FEMI is a foundation model trained on ~18 million time-lapse embryo images for comprehensive, non-invasive assessment of embryo viability and development
  • Self-supervised learning approach enables comprehensive feature extraction without manual annotation requirements
  • A single unified platform handles multiple critical assessment tasks through task-specific fine-tuning
  • PoC Data: Achieves >0.75 AUROC for ploidy prediction using single images, improving to >0.80 AUROC with video sequences and >0.85 AUROC when including maternal age data
  • Demonstrates >90% F1 score in embryo tracking across 96-112 hours post-insemination
  • Predicts developmental timing with mean absolute errors under 6 hours across datasets

Technology Applications

  • Clinical decision support tool for IVF clinics enabling standardized embryo selection
  • Potential applications in broader reproductive medicine research and developmental biology for studying embryo morphology and development patterns

Technology Advantages

  • State-of-the-art performance across multiple embryo assessment tasks
  • Standardized, objective analysis with generalization across multiple clinical settings and datasets, enabling consistent embryo assessment protocols
  • Provides cost-effective implementation through seamless integration with existing time-lapse imaging equipment in IVF clinics

Overview of FEMI and downstream applications.

Intellectual Property

Patents

  • US Patent 12,014,833: "System and method for selecting artificially fertilized embryos"
  • IL Patent 280645: "System and method for selecting artificially fertilized embryos"
  • US Application: "Predicting embryo ploidy status using time-lapse images"
  • Provisional Application Filed

Cornell Reference

  • 11620

Contact Information

Blonde Caucasian woman wearing a dark brown turtle neck

For additional information please contact

Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 780-8775
Email: djr296@cornell.edu